Compare ESE & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESE | CRL |
|---|---|---|
| Founded | 1990 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.6B |
| IPO Year | 1994 | 1999 |
| Metric | ESE | CRL |
|---|---|---|
| Price | $316.48 | $188.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $283.33 | $198.27 |
| AVG Volume (30 Days) | 227.7K | ★ 788.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | ★ 193.15 | N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | $37,000,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $21.42 | N/A |
| Revenue Next Year | $6.99 | $3.04 |
| P/E Ratio | $128.95 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $174.92 | $143.06 |
| 52 Week High | $346.20 | $228.88 |
| Indicator | ESE | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 61.35 |
| Support Level | $283.70 | $161.39 |
| Resistance Level | $346.20 | $197.12 |
| Average True Range (ATR) | 9.34 | 8.58 |
| MACD | 2.03 | 2.19 |
| Stochastic Oscillator | 95.64 | 87.09 |
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.